{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P49841",
      "entity_text" : "p-GSK3beta",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "Cellular_component" : [ "go:GO:0005739" ],
      "Species" : [ "taxonomy:10535" ]
    }
  },
  "verbose_text" : "As shown in XREF_FIG, H/SD treatment (H/SD, 0.322 +/-0.043; EGFP-Adv + H/SD, 0.389 +/-0.053) decreased p-GSK3beta expression compared with in the control (0.752 +/-0.062; P < 0.05), EGFP-Adv (0.829 +/-0.034; P < 0.05) and EGFP-ADM groups (0.708 +/-0.035; P < 0.05), whereas the expression levels of inactivated p-GSK3beta were significantly enhanced in the EGFP-ADM + H/SD group (0.732 +/-0.042) compared with in the H/SD group (P < 0.05).",
  "reading_complete" : "2020-08-02T13:38:38Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T13:35:31Z",
  "trigger" : "expression",
  "evidence" : [ "p-GSK3beta expression" ],
  "pmc_id" : "5881801",
  "score" : 0
}